<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In children, <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) represent less then 10% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e>; consequently, molecular genetic studies dealing with this group of patients are scarce </plain></SENT>
<SENT sid="1" pm="."><plain>We have analyzed 35 archival bone marrow samples of children with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> for the presence of mutations in the first and second exons of the NRAS and KRAS2 genes </plain></SENT>
<SENT sid="2" pm="."><plain>Mutations were detected with single-strand conformation polymorphism analysis in three patients </plain></SENT>
<SENT sid="3" pm="."><plain>One patient harbored a mutation in the second exon of NRAS and two patients in the second exon of KRAS2 </plain></SENT>
<SENT sid="4" pm="."><plain>Sequencing was performed in two samples and novel mutations were found in both </plain></SENT>
<SENT sid="5" pm="."><plain>One patient had a missense mutation in codon 45 of NRAS; the other had a silent mutation in codon 53 and a missense mutation in codon 55 of KRAS2 </plain></SENT>
</text></document>